Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLH | Q9Y253 | 8/20 | 0.92 |
| ▸ | MEN1 | O00255 | 8/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.92 |
| ▸ | MAPT | P10636 | 7/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.92 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.92 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.92 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.92 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.92 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.92 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.92 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.92 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.92 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 0.92 |
| ▸ | HPGD | P15428 | 4/20 | 0.92 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.92 |
| ▸ | XDH | P47989 | 4/20 | 0.92 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.92 |
| ▸ | TP53 | P04637 | 4/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Luteolin SCHEMBL29352380 | 0.96 | POLH (1.00) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL30045580 | 0.96 | POLH (1.00) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL28256564 | 0.96 | POLH (1.00) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL29376494 | 0.96 | POLH (1.00) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL20426 | 0.96 | POLH (1.00) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL31542150 | 0.94 | POLH (0.97) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL31168048 | 0.94 | POLH (0.97) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL31539190 | 0.94 | POLH (0.97) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL31678931 | 0.94 | POLH (0.97) | POLHMEN1KMT2AMAPTALDH1A1 | |
| Luteolin SCHEMBL1659262 | 0.94 | POLH (0.97) | POLHMEN1KMT2AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080268024-A1 | Compositions for Oral and/or Topical Administration | COGNIS IP MANAGEMENT GMBH (DE) | 2008-10-30 | — | — | US | claimed |
| WO-2024011228-A1 | PLANT BASED HONEY COMPOSITION | Melibio, Inc. (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-102579540-B | Preparation method and application of sowthistle-leaf ixeris seedling flavonoid aglycone | Shenyang shuangding pharmaceutical co ltd | 2014-08-06 | — | — | CN | disclosed |
| CN-102579540-A | Preparation method and application of sowthistle-leaf ixeris seedling flavonoid aglycone | Shenyang shuangding pharmaceutical co ltd | 2012-07-18 | — | — | CN | disclosed |
| CN-101249118-A | Chinese medicine extract and medicine use thereof | HU JUN (CN) | 2008-08-27 | — | — | CN | disclosed |
| CN-101181319-A | Chinese medicine and mass control method of preparations thereof | HU JUN (CN) | 2008-05-21 | — | — | CN | disclosed |
| WO-2008046521-A1 | PREPARATION FOR ORAL ADMINISTRATION (II) | COGNIS IP MANAGEMENT GMBH (DE) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008028585-A2 | COSMETIC AND/OR PHARMACEUTICAL PREPARATIONS CONTAINING HOODIA EXTRACTS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-03-13 | — | — | WO | disclosed |
| WO-2008028584-A1 | PREPARATIONS FOR ORAL ADMINISTRATION (I) | COGNIS IP MANAGEMENT GMBH (DE) | 2008-03-13 | — | — | WO | disclosed |
| CN-101045072-A | Extractive of turnipia arguta leaves and its pharmaceutical use | HU JUN (CN) | 2007-10-03 | — | — | CN | disclosed |
| CN-101011435-A | Shanxiangyuan leaf extract, preparation method and uses thereof | HU JUN (CN) | 2007-08-08 | — | — | CN | disclosed |
| CN-101007030-A | Quality control methods of leaves of cordyalis esquirolii and its preparation | HU JUN (CN) | 2007-08-01 | — | — | CN | disclosed |
| WO-2007068390-A1 | PRE-MIXES FOR PERSONAL AND HOME CARE COMPOSITIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2007-06-21 | — | — | WO | disclosed |
| WO-2005115170-A1 | ORAL AND /OR TOPICAL COMPOSITIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2005-12-08 | — | — | WO | disclosed |
| WO-2005053435-A1 | PREPARATIONS FOR ORAL AND/OR TOPICAL APPLICATION | COGNIS IP MANAGEMENT GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |
| WO-2005053721-A1 | ANTIOXIDANT PREPARATION FOR ORAL AND/OR TOPICAL APPLICATION | COGNIS IP MANAGEMENT GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |
| EP-0263553-A2 | Method of inhibiting gene induction | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268024-A1 | Compositions for Oral and/or Topical Administration | FABP2, FABP6, CUTA | POLH 290/4885MEN1 2644/4885KMT2A 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.